« Back
ESMO Congress 2024
Sep 13 - Sep 17, 2024
Martin Wermke, MD, will present at the ESMO Congress 2024.
Date: September 16, 2024
Time: 11:25 AM CEST
Title: Initial safety, pharmacokinetics, and anti-tumor activity data of TCER IMA401, a MAGEA4/8-directed half-life extended TCR Bispecific, in Phase 1 dose escalation
For more information about the presentation, read the full press release: Immatics Announces Upcoming Oral Presentation at ESMO Congress 2024
Location
Barcelona, Spain